The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc's opioid painkiller Roxicodone, saying some parts of the company's application need further evaluation.
Johnson & Johnson said on Wednesday its drug Tremfya was more effective than a rival medicine from Novartis AG, and met the main goal of a late-stage study in adults with moderate to severe plaque psoriasis.
A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc to prescribe a highly addictive fentanyl spray the drugmaker produced.
Indivior Plc has secured another hold on the launch of a generic competitor to its best-selling opioid addiction drug in the United States, the London-listed company said on Wednesday.
Thailand is set to become the first Asian country to legalize medical marijuana, but a battle is brewing between local and foreign firms over control of a potentially lucrative market.
McDonald's Corp said on Tuesday it plans to reduce the use of antibiotics in its global beef supply, fueling projections that other restaurants will follow suit.
(Reuters Health) - - Older adults who are prescribed medication for depression by primary care physicians often fail to start taking these drugs or to continue using them as directed, a Dutch study suggests.
(Reuters Health) - - Physicians training at many of the top U.S. medical schools get much less time off for childbearing and family leave than the 12 weeks recommended by doctors, two new studies suggest.
(Reuters Health) - - Children who have an older brother or sister with autism or attention deficit hyperactivity disorder (ADHD) may be more likely to develop these conditions than kids who don't have an older sibling with these neurological problems, a new study suggests.
